A Double-Blind, Randomized Controlled Trial of Hydroxychloroquine for Cognitive Dysfunction and Inflammatory Biomarkers in Systemic Lupus Erythematosus Patients in Indonesia

A Double-Blind, Randomized Controlled Trial of Hydroxychloroquine for Cognitive Dysfunction and Inflammatory Biomarkers in Systemic Lupus Erythematosus Patients in Indonesia

BACKGROUND: Systemic lupus erythematosus (SLE) is an autoimmune condition characterized by persistent, chronic inflammation that damages organ tissue. One of the symptoms that is often found in SLE is cognitive dysfunction. Hydroxychloroquine is recommended for the treatment of all levels of SLE. Th...

Fuld beskrivelse

Bibliografiske detaljer
Main Authors:	Bantar Suntoko, Suharyo Hadisaputro, Handono Kalim, Suyanto Hadi, Ika Vemilia Warlisti
Format:	Article
Sprog:	English
Udgivet:	Secretariat of The Indonesian Biomedical Journal 2023-08-01
Serier:	Indonesian Biomedical Journal
Online adgang:	https://inabj.org/index.php/ibj/article/view/2504

Lignende værker

Relationship Between Disease Activity, Levels of IFN-a, IL-4, IL-6, and Anti-NMDA to Cognitive Dysfunction (MoCA-INA Score) in Systemic Lupus Erythematosus (SLE) Patients with Cognitive Dysfunction
af: Bantar Suntoko, et al.
Udgivet: (2023-07-01)

Diagnosis and Management of Cognitive Dysfunction In Systemic Lupus Erythematosus Patients
af: Perdana Aditya Rahman, et al.
Udgivet: (2022-05-01)

Hyperuricemia and Pro Inflammatory Cytokine (IL-1Î², IL-6, and TNF-Î±)
af: Suyanto Hadi, et al.
Udgivet: (2018-02-01)

Advancements on the impact of hydroxychloroquine in systemic lupus erythematosus
af: Liu Peng-Cheng, et al.
Udgivet: (2024-05-01)

Periodontal Tissue Condition on Systemic Lupus Erythematosus Patients: A Clinical Study
af: Nanda Rachmad Putra Gofur, et al.
Udgivet: (2022-03-01)

Hydroxychloroquine-induced retinal toxicity in systemic lupus erythematosus
af: Kisha D Piggott, et al.
Udgivet: (2018-01-01)

Hydroxychloroquine in systemic lupus erythematosus: overview of current knowledge
af: Alina Dima, et al.
Udgivet: (2022-02-01)

Periodontal Comparison on Systemic Lupus Erythematosus Patients and Healthy Subjects: A Cross-Sectional Study
af: Nanda Rachmad Putra Gofur, et al.
Udgivet: (2021-11-01)

Periodontitis is associated with disease severity and anti-double stranded DNA antibody and interferon-gamma levels in patients with systemic lupus erythematosus
af: Nanda R.P. Gofur, MS, et al.
Udgivet: (2019-12-01)

Association between senescence of T cells and disease activity in patients with systemic lupus erythematosus
af: Handono Kalim, et al.
Udgivet: (2021-10-01)

New onset bullous lupus erythematosus in a systemic lupus erythematosus patient after initiation of hydroxychloroquin
af: Chanchal Gera, et al.
Udgivet: (2014-01-01)

Hydroxychloroquine in patients with systemic lupus erythematosus: how much is enough?
af: Guillermo Ruiz-Irastorza, et al.
Udgivet: (2025-02-01)

Hydroxychloroquine in systemic lupus erythematosus and psychosis. A case report
af: M. Martínez Grimal, et al.
Udgivet: (2024-04-01)

Outcomes of Systemic Lupus Erythematosus in Patients who Discontinue Hydroxychloroquine
af: Z. Aouhab, et al.
Udgivet: (2019-11-01)

Multichannel perimetric alterations in systemic lupus erythematosus treated with hydroxychloroquine
af: David P. Piñero, et al.
Udgivet: (2017-04-01)

Influence of hydroxychloroquine blood levels on adhesion molecules associated with endothelial dysfunction in patients with systemic lupus erythematosus
af: Michele Iudici, et al.
Udgivet: (2022-03-01)

Oral Hygiene and Dental Caries Status on Systemic Lupus Erythematosus Patients: A Cross-Sectional Study
af: Nanda Rachmad Putra Gofur, et al.
Udgivet: (2022-03-01)

Protective Effects of Hydroxychloroquine against Accelerated Atherosclerosis in Systemic Lupus Erythematosus
af: Alberto Floris, et al.
Udgivet: (2018-01-01)

Hydroxychloroquine lowers the risk for Diabetes Mellitus in patients with Systemic Lupus Erythematosus
af: Dennis Levinson, et al.
Udgivet: (2022-10-01)

The phenotype of CD3–CD56bright and CD3–CD56dim natural killer cells in systemic lupus erythematosus patients and its relation to disease activity
af: Dwi Soelistyoningsih, et al.
Udgivet: (2022-08-01)

Assessment of SLEDAI score changes in systemic lupus erythematosus patients under low-dose interleukin-2 therapy: A meta-analysis
af: Dwi Soelistyoningsih, et al.
Udgivet: (2024-09-01)

S15.1 Hydroxychloroquine daily dose, hydroxychloroquine blood levels and the risk of flares in patients with systemic lupus erythematosus
af: S Fasano, et al.
Udgivet: (2022-10-01)

The Correlation between Serum Concentration of Vitamin D with Vitamin D Receptor Expression and Disease Activity in Indonesian Patients with Systemic Lupus Erythematosus: Preliminary Study
af: Kusworini Handono, et al.
Udgivet: (2014-05-01)

Hydroxychloroquine treatment in European patients with lupus erythematosus: dosing, retinopathy screening and adherence
af: Ronald F van Vollenhoven, et al.
Udgivet: (2021-04-01)

Successful treatment of cardiac tamponade with systemic lupus erythematosus using belimumab and hydroxychloroquine
af: Tomoo Kise, et al.
Udgivet: (2023-01-01)

An observational study to identify causative factors for not using hydroxychloroquine in systemic lupus erythematosus
af: Atsushi Manabe, et al.
Udgivet: (2024-04-01)

Effect of hydroxychloroquine blood concentration on the efficacy and ocular toxicity of systemic lupus erythematosus
af: Peng-Cheng Liu, et al.
Udgivet: (2024-04-01)

Evaluation of Hydroxychloroquine Blood Concentrations and Effects in Childhood-Onset Systemic Lupus Erythematosus
af: Noël Zahr, et al.
Udgivet: (2021-03-01)

Incidental retinal vascular occlusions on hydroxychloroquine screening in patients with systemic lupus erythematosus
af: Bajwa A, et al.
Udgivet: (2015-05-01)

Hydroxychloroquine-Induced Psoriasis-form Erythroderma in a Patient with Systemic Lupus Erythematosus
af: Wen-Ming Wang, et al.
Udgivet: (2018-01-01)

Extensive discoid lupus erythematosus in a HIV patient responding to hydroxychloroquine monotherapy
af: Pradeep Vittal Bhagwat, et al.
Udgivet: (2012-01-01)

Frequency and risk factors for hydroxychloroquine retinopathy among patients with systemic lupus erythematosus
af: Mohammed Salah Eldin Abdelbaky, et al.
Udgivet: (2021-06-01)

CS-31 Safety of hydroxychloroquine withdrawal in older adults with systemic lupus erythematosus
af: Anca Askanase, et al.
Udgivet: (2018-08-01)

Oculometric biomarkers of visuomotor deficits in clinically asymptomatic patients with systemic lupus erythematosus undergoing long-term hydroxychloroquine treatment
af: Andrew R. Berneshawi, et al.
Udgivet: (2024-07-01)

Hydroxychloroquine is associated with lower platelet activity and improved vascular health in systemic lupus erythematosus
af: Peter Izmirly, et al.
Udgivet: (2021-04-01)

Life Threatening Severe QTc Prolongation in Patient with Systemic Lupus Erythematosus due to Hydroxychloroquine
af: John P. O’Laughlin, et al.
Udgivet: (2016-01-01)

O9 Early pregnancy exposure to hydroxychloroquine and preterm delivery in systemic lupus erythematosus
af: Elisabet Svenungsson, et al.
Udgivet: (2024-03-01)

Nationwide patterns of hydroxychloroquine dosing and monitoring of retinal toxicity in patients with systemic lupus erythematosus
af: Jae-Eun Lee, et al.
Udgivet: (2023-05-01)

Hydroxychloroquine-induced hyperpigmentation in a 14-year-old female with systemic lupus erythematosus
af: Alexander KC Leung, et al.
Udgivet: (2020-07-01)

Discontinuation of hydroxychloroquine in older patients with systemic lupus erythematosus: a multicenter retrospective study
af: Ruth Fernandez-Ruiz, et al.
Udgivet: (2020-08-01)